Latest filings (excl ownership)
REVOKED
Registration or securities revoked
28 Jul 17
8-K
Other Events
12 May 11
8-K
Unregistered Sales of Equity Securities
3 May 11
424B1
Prospectus with pricing info
22 Apr 11
8-K
Entry into a Material Definitive Agreement
22 Apr 11
EFFECT
Notice of effectiveness
20 Apr 11
DEF 14A
Definitive proxy
13 Apr 11
8-K
Changes in Registrant's Certifying Accountant
8 Apr 11
POS AM
Prospectus update (post-effective amendment)
8 Apr 11
PRER14A
Preliminary revised proxy
7 Apr 11
PRE 14A
Preliminary proxy
4 Apr 11
10-K
2010 FY
Annual report
24 Mar 11
8-K
Results of Operations and Financial Condition
24 Mar 11
8-K
Unregistered Sales of Equity Securities
17 Mar 11
424B3
Prospectus supplement
2 Mar 11
8-K
Entry into a Material Definitive Agreement
2 Mar 11
8-K
Unregistered Sales of Equity Securities
23 Feb 11
424B1
Prospectus with pricing info
31 Jan 11
EFFECT
Notice of effectiveness
28 Jan 11
8-K
Entry into a Material Definitive Agreement
21 Jan 11
S-1
IPO registration
18 Jan 11
8-K
Unregistered Sales of Equity Securities
14 Jan 11
8-K
Entry into a Material Definitive Agreement
4 Jan 11
8-K
Unregistered Sales of Equity Securities
29 Dec 10
8-K
Unregistered Sales of Equity Securities
8 Dec 10
8-K
Entry into a Material Definitive Agreement
30 Nov 10
424B3
Prospectus supplement
16 Nov 10
10-Q
2010 Q3
Quarterly report
12 Nov 10
8-K
Advanced Life Sciences Announces Third Quarter 2010 Financial Results
12 Nov 10
8-K
Departure of Directors or Certain Officers
3 Nov 10
EFFECT
Notice of effectiveness
18 Oct 10
CORRESP
Correspondence with SEC
14 Oct 10
CORRESP
Correspondence with SEC
13 Oct 10
UPLOAD
Letter from SEC
12 Oct 10
8-K
Entry into a Material Definitive Agreement
29 Sep 10
S-1
IPO registration
29 Sep 10
8-K
Entry into a Material Definitive Agreement
15 Sep 10
424B3
Prospectus supplement
12 Aug 10
10-Q
2010 Q2
Quarterly report
11 Aug 10
424B3
Prospectus supplement
27 Jul 10
Latest ownership filings